临床研究是不是不如基础研究好中标?

2021-08-17 MedSci原创 MedSci原创

临床研究是不是不如基础研究好中标-11.

《梅斯直播课:2020年国自然申请专题训练营——2020年国自然申请资助最新政策解析及未来趋势分析》

回答问题11:临床研究是不是不如基础研究好中标?

 

欢迎点赞、评论、分享

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1009244, encodeId=f6cb100924453, content=很有用,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Wed Aug 18 20:18:01 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009080, encodeId=24201009080d9, content=临床研究也可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:31 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009079, encodeId=361f10090e9c9, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:22 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009078, encodeId=317510090e853, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:17 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009077, encodeId=b06010090e71a, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:16 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009076, encodeId=a18710090e6ea, content=确实, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:10 CST 2021, time=2021-08-18, status=1, ipAttribution=)]
    2021-08-18 仓央嘉措

    很有用,学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1009244, encodeId=f6cb100924453, content=很有用,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Wed Aug 18 20:18:01 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009080, encodeId=24201009080d9, content=临床研究也可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:31 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009079, encodeId=361f10090e9c9, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:22 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009078, encodeId=317510090e853, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:17 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009077, encodeId=b06010090e71a, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:16 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009076, encodeId=a18710090e6ea, content=确实, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:10 CST 2021, time=2021-08-18, status=1, ipAttribution=)]
    2021-08-18 小火龙111

    临床研究也可以

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1009244, encodeId=f6cb100924453, content=很有用,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Wed Aug 18 20:18:01 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009080, encodeId=24201009080d9, content=临床研究也可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:31 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009079, encodeId=361f10090e9c9, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:22 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009078, encodeId=317510090e853, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:17 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009077, encodeId=b06010090e71a, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:16 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009076, encodeId=a18710090e6ea, content=确实, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:10 CST 2021, time=2021-08-18, status=1, ipAttribution=)]
    2021-08-18 小火龙111

    很有用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1009244, encodeId=f6cb100924453, content=很有用,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Wed Aug 18 20:18:01 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009080, encodeId=24201009080d9, content=临床研究也可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:31 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009079, encodeId=361f10090e9c9, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:22 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009078, encodeId=317510090e853, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:17 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009077, encodeId=b06010090e71a, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:16 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009076, encodeId=a18710090e6ea, content=确实, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:10 CST 2021, time=2021-08-18, status=1, ipAttribution=)]
    2021-08-18 小火龙111

    nice

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1009244, encodeId=f6cb100924453, content=很有用,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Wed Aug 18 20:18:01 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009080, encodeId=24201009080d9, content=临床研究也可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:31 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009079, encodeId=361f10090e9c9, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:22 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009078, encodeId=317510090e853, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:17 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009077, encodeId=b06010090e71a, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:16 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009076, encodeId=a18710090e6ea, content=确实, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:10 CST 2021, time=2021-08-18, status=1, ipAttribution=)]
    2021-08-18 小火龙111

    学到了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1009244, encodeId=f6cb100924453, content=很有用,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Wed Aug 18 20:18:01 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009080, encodeId=24201009080d9, content=临床研究也可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:31 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009079, encodeId=361f10090e9c9, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:22 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009078, encodeId=317510090e853, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:17 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009077, encodeId=b06010090e71a, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:16 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009076, encodeId=a18710090e6ea, content=确实, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/23cddf8b4fd64eb993e1ce0dc039919a/a5d2416ef1744efb8a761e2b41df007f.jpg, createdBy=f9635507778, createdName=小火龙111, createdTime=Wed Aug 18 14:31:10 CST 2021, time=2021-08-18, status=1, ipAttribution=)]
    2021-08-18 小火龙111

    确实

    0

相关资讯

五篇基础的SCI,申请2018年国自然(NSFC)够不够?

群里近期比较活跃,当然也经常有医生朋友咨询我们:老师,我有五篇基础的SCI,申请国自然(NSFC)够不够,有希望吗?这个问题,其实也比较容易回答,不过要分几种情况,我们逐一列出:

换了研究方向,所以没有科研基础,这样的情况下申请国自然青年是不是希望不大?

换了研究方向,所以没有科研基础,这样的情况下申请国自然青年是不是希望不大-7

2017年国自然(NSFC)约80%未获得资助,你想申诉复审吗?

8月17日NSFC终于放榜,今年的资助率约在21.2%,因此大约近80%未获得资助。

国家自然科学基金查询系统-NSFC查询

请输入项目关键词,如项目名称/负责人/批准号/单位名称等

临床发表的SCI在2018年国自然(NSFC)申请中的作用

今天,我们来聊一下:临床发表的SCI与国自然(NSFC)的关系。

研究线粒体胞吐可以选择原创吗?

研究线粒体胞吐可以选择原创吗-8